CYP2E1 and glioblastoma: We also developed a potent inhibitor of CYP2E1, Q11, as an effective glioma anti‐inflammatory agent for the treatment of GBM, findings provide a perspective on anti‐inflammatory GBM therapy and offer a new potential treatment strategy for GBM.